Sherri Douville is the dynamic CEO and Board Member of Medigram, leading all-star multi-industry teams to revolutionize healthcare through cutting-edge AI-enabled mobile medical technology. Recognized in the top 1% of tech leaders, Sherri’s visionary approach and deep expertise drive significant industry impact, inspiring engagement where she is honored to advise, partner with, and coach investors, employees, and industry market leaders on solving the complexity of technology driven healthcare transformation. With a B.S. in combined sciences and top scores for MIT in AI and ML certificates, Sherri has a robust technical foundation. Her tenure at Johnson & Johnson, where she excelled across numerous disease states with an ethical approach earned her awards and external recognition from McGraw-Hill.

​

As co-chair of the IEEE/UL P2933 standard SG for trust in clinical IoT and Founder/Chair of the Trustworthy Technology and Innovation Consortium (TTIC), Sherri champions industry standards ensuring healthcare technology safety and reliability. Her strategic insights and proactive regulatory approach make her a trusted leader in healthcare IT. She is a former member of the NorCal HIMSS board and advises corporate board readiness programs at Santa Clara University.

​

Sherri’s influence extends beyond Medigram, shaping policies and practices prioritizing data security and patient privacy. As a Taylor & Francis series editor, a prestigious and rare distinction, she curates groundbreaking insights in healthcare technology. Her unique blend of technical expertise, strategic vision, and respected leadership positions her to lead healthcare technology into its next chapter, driving transformative innovation, trust, and excellence. Investors, industry leaders, and employees can look to Sherri as a driver of transformative leadership to make a lasting impact on the future of healthcare.